Risk Factors for Diabetes After Stem Cell Transplantation

NCT00539851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2010-03-19

No results posted yet for this study

Summary

This study is proposed to investigate the incidence of Post Transplant Diabetes Mellitus (PTDM) as well as associated risk factors for the development of PTDM in patients undergoing allogenic stem cell transplantation.

Conditions

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY
  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Shubhada Jagasia, MD · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-08-31
Completion
2010-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00539851 on ClinicalTrials.gov